Long-acting Injectable Antipsychotics in First-episode Schizophrenia
Open Access
- 28 April 2013
- journal article
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 11 (1) , 1-6
Abstract
Jeong HG, et al. Clin Psychopharmacol Neurosci. 2013 Apr;11(1):1-6. http://dx.doi.org/10.9758/cpn.2013.11.1.1Keywords
This publication has 34 references indexed in Scilit:
- The Role of the Family and Improvement in Treatment Maintenance, Adherence, and Outcome for SchizophreniaJournal of Clinical Psychopharmacology, 2011
- A Randomized Controlled Trial of Long-Acting Injectable Risperidone vs Continuation on Oral Atypical Antipsychotics for First-Episode Schizophrenia PatientsThe Journal of Clinical Psychiatry, 2009
- Oral versus injectable antipsychotic treatment in early psychosis: Post hoc comparison of two studiesClinical Therapeutics, 2008
- Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injectionInternational Clinical Psychopharmacology, 2008
- Long-Acting Injectable Risperidone in the Treatment of Subjects With Recent-Onset PsychosisJournal of Clinical Psychopharmacology, 2008
- The case for long‐acting antipsychotic agents in the post‐CATIE eraActa Psychiatrica Scandinavica, 2007
- Long‐term treatment with long‐acting risperidone in Korean patients with schizophreniaHuman Psychopharmacology: Clinical and Experimental, 2006
- Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up studyBMJ, 2006
- Long-Acting Injectable Antipsychotics in the ElderlyDrugs & Aging, 2003
- Depot neuroleptics in relapse preventionInternational Clinical Psychopharmacology, 1995